Viewing Study NCT04354961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-27 @ 9:45 PM
Study NCT ID: NCT04354961
Status: UNKNOWN
Last Update Posted: 2023-11-08
First Post: 2020-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma
Sponsor: Fujian Cancer Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Adenosquamous Carcinoma View
Keywords: